What is it about?

LADA is an autoimmune disorder which is often misdiagnosed. Early diagnosis is essential in limiting disease progression and C-peptide levels and autoantibodies against β-cells are the most critical diagnostic biomarkers in LADA. Thus LADA is about misdiagnosis with T1DM and T2DM

Featured Image

Why is it important?

Our findings shows the essential biomarkers to diagnose LADA and to avoid confusion with other biomarkers and diabetes disease likE T1DM and T2DM. It supports the need to carry out further research in clinical prevalence to improvise the classification in clinical setting and do provide healthy lifestyle by avoiding more drugs and setting targeted approach for clinicians.


Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations. This article also lead to rare disease groups contacting me by physicians and ultimately to a greater involvement in rare disease research. I feel this article will highlight the importance of biomarkers discovery and essential to proper diagnosis and ultimately leading to targeted therapy. This will be economically helpful for patients and lead to better health outcome.

Ankul Singh S
SRM University

Read the Original

This page is a summary of: Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset Autoimmune Diabetes in Adults: A Concise Review, Current Diabetes Reviews, January 2023, Bentham Science Publishers, DOI: 10.2174/1573399818666220324095918.
You can read the full text:



The following have contributed to this page